lisinopril medication belonging drug class angiotensinconverting enzyme ace inhibitors used treat high blood pressure heart failure heart high blood pressure usually firstline treatment also used prevent kidney problems people diabetes lisinopril taken full effect may take four weeks common side effects include headache dizziness feeling tired cough nausea serious side effects may include low blood pressure liver problems high blood potassium use recommended entire duration pregnancy may harm lisinopril works inhibiting lisinopril patented approved medical use united states available generic fourth commonly prescribed medication united states million july oral solution formulation lisinopril approved use united lisinopril typically used treatment high blood pressure congestive heart failure diabetic nephropathy acute myocardial infarction heart lisinopril part ace inhibitors drug lisinopril indicated treatment hypertension adjunctive therapy heart failure acute myocardial lisinopril contraindicated people history angioedema hereditary idiopathic diabetes taking common side effects include headache dizziness feeling tired cough nausea serious side effects may include low blood pressure liver problems high blood potassium use recommended entire duration pregnancy may harm animal human data revealed evidence harm embryo teratogenicity associated ace aceinhibitors like lisinopril considered generally safe people undergoing routine dental care though use lisinopril prior dental surgery controversial dentists recommending discontinuation morning people may present dental care suspicious infected tooth swelling around mouth may due lisinoprilinduced angioedema prompting emergency medical lisinopril lysineanalog enalapril unlike ace inhibitors prodrug metabolized liver excreted unchanged lisinopril ace inhibitor meaning blocks actions angiotensinconverting enzyme ace system raas preventing angiotensin converted angiotensin ii angiotensin ii potent direct vasoconstrictor stimulator aldosterone release reduction amount angiotensin ii results relaxation arterioles reduction amount angiotensin ii also reduces release aldosterone adrenal cortex allows kidney excrete sodium along water urine increases retention potassium specifically process occurs peritubular capillaries kidneys response change starling inhibition raas system causes overall decrease blood following oral administration lisinopril peak serum concentrations lisinopril occur within seven although trend small delay time taken reach peak serum concentrations acute myocardial infarction patients peak effect lisinopril hours declining serum concentrations exhibit prolonged terminal phase contribute drug accumulation terminal phase probably represents saturable binding ace proportional dose lisinopril undergo metabolism absorbed drug excreted unchanged entirely urine based urinary recovery mean extent absorption lisinopril approximately reduced people new york heart association functional classification nyha class heart failure large interpatient variability doses tested lisinopril absorption affected presence food gastrointestinal studies rats indicate lisinopril crosses bloodbrain barrier poorly multiple doses lisinopril rats result accumulation tissuesmedical citation needed lisinopril bind proteins distribute well people nyha class heart lisinopril watersoluble member ace inhibitor class metabolism lisinopril leaves body completely unchanged halflife lisinopril hours increased people kidney plasma halflife lisinopril estimated hours elimination halflife much longer around full duration action pure lisinopril powder white white lisinopril soluble water approximately mgl room less soluble methanol virtually insoluble captopril first ace inhibitor functional structural analog peptide derived venom jararaca brazilian pit viper bothrops enalapril derivative designed scientists merck overcome rash bad taste caused enalapril actually prodrug active metabolite diacid metabolite enalapril enalaprilat lysine analogue lisinopril potent inhibitors angiotensin converting enzyme ace contain sulphydryl groups drugs assayed high pressure liquid chromatography radioimmunoassay plasma ace inhibition remains stable normal storage conditions therefore possible study pharmacokinetics well pharmacodynamic effects humans enalaprilat lisinopril well ace activity measured blood taken course two studies effects drugs blood pressure autonomic responsiveness lisinopril synthetic peptide derivative scientists merck created lisinopril systematically altering structural unit enalaprilat substituting various amino acids adding lysine one end drug turned strong activity adequate bioavailability given orally analogs compound resulted lisinopril takes name discovery lysine merck conducted clinical trials drug approved hypertension congestive heart failure discovery posed problem since sales enalapril strong merck company want diminish sales merck ended entering agreement zeneca zeneca received right comarket lisinopril merck received exclusive rights earlier stage aldose reductase inhibitor drug candidate potential treatment diabetes zenecas marketing brand name zestril turned stronger mercks drug became blockbuster astrazeneca formed annual sales us patents expired since lisinopril available many brand names worldwide also available combination drugs diuretic hydrochlorothiazide lisinoprilhydrochlorothiazide calcium channel blocker amlodipine httpsenwikipediaorgwikilisinopril